The ET Most Innovative AI Product Awards 2026 aims to celebrate organizations that are leveraging artificial intelligence (AI) to transform the life sciences and pharmaceutical sectors in India. This award category recognizes impactful AI-led products and platforms that are enhancing drug discovery, clinical development, and personalized medicine. As the healthcare landscape becomes increasingly data-driven and complex, the need for efficient and scientifically rigorous solutions is paramount. The awards will spotlight innovations that streamline research processes, optimize clinical trials, and accelerate the journey from discovery to treatment. Organizations eligible for nomination include pharmaceutical and biotech research and development teams, clinical research organizations, life sciences AI startups, and AI-powered research platforms. Evaluation criteria will focus on the ability to reduce costs and time in drug development workflows, improve accuracy in target identification, and enhance trial design efficiency. The awards will also consider scientific credibility and evidence-backed outcomes, ensuring that nominated solutions demonstrate real-world effectiveness. Overall, the ET Most Innovative AI Product Awards 2026 aims to highlight how emerging technologies are reshaping the future of healthcare innovation.